Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Max Drawdown (5Y) : 94.19% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.19% |
| August 31, 2026 | 94.19% |
| July 31, 2026 | 94.19% |
| June 30, 2026 | 94.19% |
| May 31, 2026 | 94.19% |
| April 30, 2026 | 94.19% |
| March 31, 2026 | 94.19% |
| February 28, 2026 | 94.19% |
| Date | Value |
|---|---|
| January 31, 2026 | 94.19% |
| December 31, 2025 | 94.19% |
| November 30, 2025 | 94.19% |
| October 31, 2025 | 94.19% |
| September 30, 2025 | 94.19% |
| August 31, 2025 | 93.93% |
| July 31, 2025 | 93.93% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Agilent Technologies, Inc. | 43.19% |
| Bio-Rad Laboratories, Inc. | 73.77% |
| Bruker Corp. | 68.72% |
| Danaher Corp. | 43.81% |
| Harvard Bioscience, Inc. | 96.64% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -36.48 |
| Beta (5Y) | 0.7305 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.37% |
| Historical Sharpe Ratio (5Y) | -0.3722 |
| Historical Sortino (5Y) | -0.7694 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.27% |